Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1984 1
1985 1
1986 1
1987 1
1988 1
1991 1
1992 1
1993 2
1994 2
1995 5
1996 2
1997 1
1998 3
1999 5
2000 2
2001 1
2002 6
2003 1
2004 4
2005 2
2006 3
2007 5
2008 5
2009 6
2010 6
2011 8
2012 4
2013 3
2014 4
2015 6
2016 9
2017 6
2018 5
2019 6
2020 4
2021 3
2022 6
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Results by year

Filters applied: . Clear all
Page 1
Outcome Evaluation of Repeat Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations.
Mantziaris G, Pikis S, Dumot C, Dayawansa S, Liščák R, May J, Lee CC, Yang HC, Martinez Moreno N, Martinez Álvarez R, Lunsford LD, Niranjan A, Wei Z, Srinivasan P, Tang LW, Nabeel AM, Reda WA, Tawadros SR, Abdelkarim K, El-Shehaby AMN, Emad RM, Hesham Elazzazi A, Peker S, Samanci Y, Padmanaban V, Jareczek FJ, McInerney J, Cockroft KM, Mathieu D, Aldakhil S, Alzate JD, Kondziolka D, Tripathi M, Palmer JD, Upadhyay R, Lin M, Zada G, Yu C, Cifarelli CP, Cifarelli DT, Xu Z, Sheehan JP. Mantziaris G, et al. Stroke. 2023 Aug;54(8):1974-1984. doi: 10.1161/STROKEAHA.123.042515. Epub 2023 Jun 23. Stroke. 2023. PMID: 37350270
BACKGROUND: Repeat stereotactic radiosurgery (SRS) for persistent cerebral arteriovenous malformation (AVM) has generally favorable patient outcomes. ...RESULTS: The cohort comprised 505 patients (254 [50.3%] males; median [interquartile range] age, 34 [15] y …
BACKGROUND: Repeat stereotactic radiosurgery (SRS) for persistent cerebral arteriovenous malformation (AVM) has general …
Seizure Outcomes After Interventional Treatment in Cerebral Arteriovenous Malformation-Associated Epilepsy: A Systematic Review and Meta-Analysis.
Lak AM, Cerecedo-Lopez CD, Cha J, Aziz-Sultan MA, Frerichs KU, Gormley WB, Mekary RA, Du R, Patel NJ. Lak AM, et al. World Neurosurg. 2022 Apr;160:e9-e22. doi: 10.1016/j.wneu.2021.09.063. World Neurosurg. 2022. PMID: 35364673
METHODS: PubMed, Embase, and Web of Science were searched on December 31, 2020 for studies that evaluated outcomes in patients with AVM-associated epilepsy after undergoing different treatment modalities. Pooled analysis was performed using a random-effects model and strat …
METHODS: PubMed, Embase, and Web of Science were searched on December 31, 2020 for studies that evaluated outcomes in patients with AVM-asso …
Treatment guidelines for cerebral arteriovenous malformation microsurgery.
Starke RM, Komotar RJ, Hwang BY, Fischer LE, Garrett MC, Otten ML, Connolly ES. Starke RM, et al. Br J Neurosurg. 2009 Aug;23(4):376-86. doi: 10.1080/02688690902977662. Br J Neurosurg. 2009. PMID: 19637008 Review.
The goal of cerebral arteriovenous malformation (AVM) treatment is to eliminate intracerebral hemorrhage risk and to preserve or maximize neurological functions of the patient. Interventional planning must determine the modality or combination of modalities w …
The goal of cerebral arteriovenous malformation (AVM) treatment is to eliminate intracerebral hemorrhage risk and to pr …
Stereotactic Radio Surgery, Embolization and Conservative Management for Cerebral Arteriovenous Malformation: A New Zealand Experience of Long-Term Outcomes.
Bethanabatla R, Spencer T, Kelly L, Gan P, Taha A. Bethanabatla R, et al. World Neurosurg. 2022 Aug;164:e992-e1000. doi: 10.1016/j.wneu.2022.05.088. Epub 2022 May 26. World Neurosurg. 2022. PMID: 35643401
CONCLUSIONS: Findings suggest that SRS and ESRS are safe and effective treatments for cerebral AVM (when quantified by obliteration, rebleed, and disease-specific mortality rates). With multinational, prospective, randomized controlled trials with long follow-up periods, t …
CONCLUSIONS: Findings suggest that SRS and ESRS are safe and effective treatments for cerebral AVM (when quantified by obliteration, rebleed …
Efficacy and morbidity of arc-therapy radiosurgery for cerebral arteriovenous malformations: a comparison with the natural history.
Bollet MA, Anxionnat R, Buchheit I, Bey P, Cordebar A, Jay N, Desandes E, Marchal C, Lapeyre M, Aletti P, Picard L. Bollet MA, et al. Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1353-63. doi: 10.1016/j.ijrobp.2003.09.005. Int J Radiat Oncol Biol Phys. 2004. PMID: 15050310 Review.
PURPOSE: To report the results of arc-therapy radiosurgery for cerebral arteriovenous malformation (AVM) and to compare the adverse event rate with the rate expected from the natural history. ...
PURPOSE: To report the results of arc-therapy radiosurgery for cerebral arteriovenous malformation (AVM) and to compare …
Onyx: a unique neuroembolic agent.
Ayad M, Eskioglu E, Mericle RA. Ayad M, et al. Expert Rev Med Devices. 2006 Nov;3(6):705-15. doi: 10.1586/17434440.3.6.705. Expert Rev Med Devices. 2006. PMID: 17280535 Review.
Rupture of a cerebral arteriovenous malformation can result in devastating hemorrhage with a possibility of serious neurological injury or death. ...
Rupture of a cerebral arteriovenous malformation can result in devastating hemorrhage with a possibility of serious neu …
Multicenter assessment of morbidity associated with cerebral arteriovenous malformation hemorrhages.
Fukuda K, Majumdar M, Masoud H, Nguyen T, Honarmand A, Shaibani A, Ansari S, Tan LA, Chen M. Fukuda K, et al. J Neurointerv Surg. 2017 Jul;9(7):664-668. doi: 10.1136/neurintsurg-2016-012485. Epub 2016 Jun 22. J Neurointerv Surg. 2017. PMID: 27334979
BACKGROUND: The optimal management strategy for unruptured cerebral arteriovenous malformations (AVMs) is controversial since the ARUBA trial (A Randomized trial of Unruptured Brain AVMs). An accurate understanding of the morbidity associated with AVM hemorrh …
BACKGROUND: The optimal management strategy for unruptured cerebral arteriovenous malformations (AVMs) is controversial since the ARUBA t …
MicroRNA-18a improves human cerebral arteriovenous malformation endothelial cell function.
Ferreira R, Santos T, Amar A, Tahara SM, Chen TC, Giannotta SL, Hofman FM. Ferreira R, et al. Stroke. 2014 Jan;45(1):293-7. doi: 10.1161/STROKEAHA.113.003578. Epub 2013 Nov 7. Stroke. 2014. PMID: 24203843
BACKGROUND AND PURPOSE: Cerebral arteriovenous malformation (AVM) is a vascular disease that disrupts normal blood flow and leads to serious neurological impairment or death. ...CONCLUSIONS: We report VEGF-D overexpression in AVM and the capacity of miR-18a t …
BACKGROUND AND PURPOSE: Cerebral arteriovenous malformation (AVM) is a vascular disease that disrupts normal blood flow …
Patterns in neurosurgical adverse events: open cerebrovascular neurosurgery.
Wong JM, Ziewacz JE, Ho AL, Panchmatia JR, Kim AH, Bader AM, Thompson BG, Du R, Gawande AA. Wong JM, et al. Neurosurg Focus. 2012 Nov;33(5):E15. doi: 10.3171/2012.7.FOCUS12181. Neurosurg Focus. 2012. PMID: 23116095 Review.
METHODS: The authors performed a PubMed search using search terms "cerebral aneurysm", "cerebral arteriovenous malformation", "intracerebral hemorrhage", "intracranial hemorrhage", "subarachnoid hemorrhage", and "complications" or "adverse events." ...
METHODS: The authors performed a PubMed search using search terms "cerebral aneurysm", "cerebral arteriovenous malformation …
121 results